Medical Research
(H300)
IRS Verified
DX Registered
990 on File
DANA-FARBER CANCER INSTITUTE
Financial strength (30%)
70/100
Reliability (20%)
70/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$3471.6M
Total Revenue
$3358.1M
Total Expenses
$3911.1M
Net Assets
9211
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
91.6%
Fundraising Efficiency
10548.7%
Operating Reserve
13.98x
Liability-to-Asset
26.9%
Revenue Diversification
75.2%
Executive Compensation
$10.7M
Compared with Peers
FY 2024
Compared with 17 similar organizations
(United States, Medical Research, $100M and over in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
91.6% | 89.4% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
6.9% | 7.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
1.5% | 0.1% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
10548.7% | 1331.2% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
14.0 mo | 12.9 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
26.9% | 29.2% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
75.2% | 92.9% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
2.5% | 6.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
11.8% | 9.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
3.3% | 0.5% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $3471.6M | $3358.1M | $3911.1M | 91.6% | 9211 |
| 2023 | $3387.6M | $3002.8M | $3360.6M | 90.7% | 8690 |
| 2022 | $2669.1M | $2558.7M | $2803.3M | 90.7% | 7998 |
| 2021 | $2417.8M | $2225.8M | N/A | — | 6996 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.